Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA365670
Max Phase: Preclinical
Molecular Formula: C23H30N4O3
Molecular Weight: 410.52
Molecule Type: Small molecule
Associated Items:
ID: ALA365670
Max Phase: Preclinical
Molecular Formula: C23H30N4O3
Molecular Weight: 410.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCO/N=C(\C)c1ccc(OCCCCCN2CCN(c3ccncc3)C2=O)cc1
Standard InChI: InChI=1S/C23H30N4O3/c1-3-30-25-19(2)20-7-9-22(10-8-20)29-18-6-4-5-15-26-16-17-27(23(26)28)21-11-13-24-14-12-21/h7-14H,3-6,15-18H2,1-2H3/b25-19+
Standard InChI Key: RZMDMQIDYWKUOF-NCELDCMTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 410.52 | Molecular Weight (Monoisotopic): 410.2318 | AlogP: 4.33 | #Rotatable Bonds: 11 |
Polar Surface Area: 67.26 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 4.52 | CX LogP: 2.77 | CX LogD: 2.77 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.31 | Np Likeness Score: -1.41 |
1. Chern JH, Lee CC, Chang CS, Lee YC, Tai CL, Lin YT, Shia KS, Lee CY, Shih SR.. (2004) Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones., 14 (20): [PMID:15380197] [10.1016/j.bmcl.2004.07.084] |
Source(1):